Lung function indices for predicting mortality in COPD

European Respiratory Journal

Volumn 42, Issue 3, 2013, Pages 616-625

  Boutou, Afroditi K ^a,b   Shrikrishna, Dinesh ^a   Tanner, Rebecca J ^a   Smith, Cayley ^a   Kelly, Julia L ^a   Ward, Simon P ^a   Polkey, Michael I ^a   Hopkinson, Nicholas S ^a  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE;

ADULT; ARTERIAL GAS; ARTICLE; BLOOD OXYGEN TENSION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FUNCTIONAL ASSESSMENT; GAS DIFFUSION; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PREDICTION; PRESSURE MEASUREMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPIROMETRY; SURVIVAL RATE; SURVIVAL TIME;

AGED; BLOOD GAS ANALYSIS; COHORT STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OXYGEN; PARTIAL PRESSURE; PLETHYSMOGRAPHY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY GAS EXCHANGE; RETROSPECTIVE STUDIES; SPIROMETRY; SURVIVAL RATE;

EID: 84883533956     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00146012     Document Type: Article

References (49)

1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2095-2128.
2. Martinez FJ, Foster G, Curtis JL, et al. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 2006; 173: 1326-1334. (Pubitemid 43900706)
3. Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Clin Chest Med 1990; 11: 555-569. (Pubitemid 20257789)
4. Kelly JL, Elkin SL, Fluxman J, et al. Breathlessness and skeletal muscle weakness in patients undergoing lung health screening in primary care. COPD 2013; 10: 40-54.
5. Shrikrishna D, Hopkinson NS. Chronic obstructive pulmonary disease: consequences beyond the lung. Clin Med 2012; 12: 71-74.
6. Antonelli Incalzi R, Fuso L, De Rosa M, et al. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J 1997; 10: 2794-2800. (Pubitemid 28052790)
7. Gudmundsson G, Gislason T, Lindberg E, et al. Mortality in COPD patients discharged from hospital: the role of treatment and co-morbidity. Respir Res 2006; 7: 109.
8. Anthonisen NR, Wright EC, Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 133: 14-20. (Pubitemid 16189089)
9. Schols AM, Slangen J, Volovics L, et al. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1791-1797.
10. Chailleux E, Laaban JP, Veale D. Prognostic value of nutritional depletion in patients with COPD treated by long-term oxygen therapy: data from the ANTADIR observatory. Chest 2003; 123: 1460-1466. (Pubitemid 36549763)
11. Swallow EB, Reyes D, Hopkinson NS, et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 2007; 62: 115-120.
12. Groenewegen KH, Schols AM, Wouters EF. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 2003; 124: 459-467. (Pubitemid 37000120)
13. Yildiz OA, Onen ZP, Sen E, et al. Predictors of long-term survival in patients with chronic obstructive pulmonary disease. Saudi Med J 2006; 27: 1866-1872. (Pubitemid 351850257)
14. Casanova C, Cote C, de Torres JP, et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171: 591-597. (Pubitemid 40365414)
15. Solanes I, Casan P, Sangenis M, et al. Factores de riesgo de mortalidad en la EPOC [Risk factors for mortality in chronic obstructive pulmonary disease.] Arch Bronconeumol 2007; 43: 445-449. (Pubitemid 47394873)
16. Haruna A, Muro S, Nakano Y, et al. CT scan findings of emphysema predict mortality in COPD. Chest 2010; 138: 635-640.
17. Nishimura K, Izumi T, Tsukino M, et al. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 121: 1434-1440. (Pubitemid 34499652)
18. Chailleux E, Fauroux B, Binet F, et al. Predictors of survival in patients receiving domiciliary oxygen therapy or mechanical ventilation. A 10-year analysis of ANTADIR Observatory. Chest 1996; 109: 741-749. (Pubitemid 26086943)
19. Boutou AK, Karrar S, Hopkinson NS, et al. Anemia and survival in chronic obstructive pulmonary disease: a dichotomous rather than a continuous predictor. Respiration 2013; 85: 126-131.
20. Divo M, Cote C, de Torres JP, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 186: 155-161.
21. Waschki B, Kirsten A, Holz O, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD. Chest 2011; 140: 331-342.
22. Gray-Donald K, Gibbons L, Shapiro SH, et al. Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153: 961-966. (Pubitemid 26081646)
23. Dallari R, Barozzi G, Pinelli G, et al. Predictors of survival in subjects with chronic obstructive pulmonary disease treated with long-term oxygen therapy. Respiration 1994; 61: 8-13. (Pubitemid 24038019)
24. Almagro P, Calbo E, Ochoa de Echaguen A, et al. Mortality after hospitalization for COPD. Chest 2002; 121: 1441-1448. (Pubitemid 34499653)
25. Celli BR, Locantore N, Yates J, et al. Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 185: 1065-1072.
26. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993; 6: Suppl. 16, 5-40.
27. Zavorsky GS, Cao J, Mayo NE, et al. Arterial versus capillary blood gases: a meta-analysis. Respir Physiol Neurobiol 2007; 155: 268-279. (Pubitemid 46177810)
28. Clark EH, Woods RL, Hughes JM. Effect of blood transfusion on the carbon monoxide transfer factor of the lung in man. Clin Sci Mol Med 1978; 54: 627-631. (Pubitemid 8359692)
29. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-555. (Pubitemid 47403272)
30. Miller MR, Pedersen OF. New concepts for expressing forced expiratory volume in 1 s arising from survival analysis. Eur Respir J 2010; 35: 873-882.
31. Miller MR, Pedersen OF, Dirksen A. A new staging strategy for chronic obstructive pulmonary disease. Int J Chron Obstr Pulmon Dis 2007; 2: 657-663.
32. Hughes JMB, Pride NB. Examination of the carbon monoxide diffusing capacity (DlCO) in relation to its Kco and Va components. Am J Respir Crit Care Med 2012; 186: 132-139.
33. Celli BR, Cote CG, Lareau SC, et al. Predictors of survival in COPD: more than just the FEV1. Respir Med 2008; 102: Suppl. 1, S27-S35. (Pubitemid 351877093)
34. Celli BR. Predictors of mortality in COPD. Respir Med 2010; 104: 773-779.
35. Vestbo J, Anderson W, Coxson HO, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE). Eur Respir J 2008; 31: 869-873.
36. Budweiser S, Jorres RA, Riedl T, et al. Predictors of survival in COPD patients with chronic hypercapnic respiratory failure receiving noninvasive home ventilation. Chest 2007; 131: 1650-1658. (Pubitemid 46981616)
37. Bang KM, Gergen PJ, Kramer R, et al. The effect of pulmonary impairment on all-cause mortality in a national cohort. Chest 1993; 103: 536-540. (Pubitemid 23070759)
38. Coleta KD, Silveira LV, Lima DF, et al. Predictors of first-year survival in patients with advanced COPD treated using long-term oxygen therapy. Respir Med 2008; 102: 512-518.
39. Lima DF, Dela Coleta K, Tanni SE, et al. Potentially modifiable predictors of mortality in patients treated with long-term oxygen therapy. Respir Med 2011; 105: 470-476.
40. Pinto-Plata VM, Cote C, Cabral H, et al. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 2004; 23: 28-33. (Pubitemid 38088492)
41. Dubois P, Machiels J, Smeets F, et al. CO transfer capacity as a determining factor of survival for severe hypoxaemic COPD patients under long-term oxygen therapy. Eur Respir J 1990; 3: 1042-1047.
42. MacNee W. Predictors of survival in patients treated with long-term oxygen therapy. Respiration 1992; 59: Suppl. 2, 5-7.
43. Domingo-Salvany A, Lamarca R, Ferrer M, et al. Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166: 680-685. (Pubitemid 34971850)
44. Moore AJ, Soler RS, Cetti EJ, et al. Sniff nasal inspiratory pressure versus IC/TLC ratio as predictors of mortality in COPD. Respir Med 2010; 104: 1319-1325.
45. Burgel PR, Roche N, Paillasseur JL, et al. Clinical COPD phenotypes identified by cluster analysis: validation with mortality. Eur Respir J 2012; 40: 495-496.
46. Burney PGJ, Hooper R. Forced vital capacity, airway obstruction and survival in a general population sample from the USA. Thorax 2011; 66: 49-54.
47. Ward H, Cooper B, Miller MR. Validation of lung function prediction equations from patient survival data. Eur Respir J 2012; 39: 1181-1187.
48. Quint JK, Donaldson GC, Hurst JR, et al. Predictive accuracy of patient-reported exacerbation frequency in COPD. Eur Respir J 2011; 37: 501-507.
49. Puhan MA, Garcia-Aymerich J, Frey M, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet 2009; 374: 704-711.